Cargando…

The efficacy and safety of targeting GM-CSF in arthritis

Detalles Bibliográficos
Autor principal:	Bykerk, Vivian P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541049/ https://www.ncbi.nlm.nih.gov/pubmed/33047107 http://dx.doi.org/10.1016/S2665-9913(20)30352-0

Ejemplares similares

Stimulating severe COVID-19: the potential role of GM-CSF antagonism
por: Leavis, Helen L, et al.
Publicado: (2022)

GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?
por: Favalli, Ennio Giulio, et al.
Publicado: (2020)

Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease
por: Potter, Huntington, et al.
Publicado: (2021)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Pharmacodynamic biomarkers and differential effects of TNF‐ and GM‐CSF‐targeting biologics in rheumatoid arthritis
por: Guo, Xiang, et al.
Publicado: (2018)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023)

GM-CSF: A Promising Target in Inflammation and Autoimmunity
por: Lee, Kevin M C, et al.
Publicado: (2020)

GM-CSF as a therapeutic target in autoimmune diseases
por: Shiomi, Aoi, et al.
Publicado: (2016)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease
por: Cook, Andrew D, et al.
Publicado: (2001)

GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis
por: Fuentelsaz-Romero, Sara, et al.
Publicado: (2021)

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
por: Bonaventura, Aldo, et al.
Publicado: (2020)

NK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS
por: Louis, Cynthia, et al.
Publicado: (2020)

GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)

Development of Dendritic Cells from GM-CSF(-/-) Mice in vitro : GM-CSF Enhances Production and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

Correction: NK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS
por: Louis, Cynthia, et al.
Publicado: (2020)

GM-CSF targeting in COVID-19: an approach based on fragile foundations
por: Kohler, Katharina, et al.
Publicado: (2023)

GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection
por: Vaillant, Laurie, et al.
Publicado: (2022)

Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
por: Shiomi, Aoi, et al.
Publicado: (2015)

A Review of GM-CSF Therapy in Sepsis
por: Mathias, Brittany, et al.
Publicado: (2015)

GM-CSF: Orchestrating the Pulmonary Response to Infection
por: McCormick, Thomas S., et al.
Publicado: (2022)

Role of GM-CSF in lung balance and disease
por: Chen, Yingzi, et al.
Publicado: (2023)

MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis
por: Jang, Jinah, et al.
Publicado: (2006)

Th1 is the predominant helper T cell subset that produces GM-CSF in the joint of rheumatoid arthritis
por: Yamada, Hisakata, et al.
Publicado: (2017)

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
por: He, Kai, et al.
Publicado: (2022)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection
por: Benmerzoug, Sulayman, et al.
Publicado: (2018)

New international guidance on quality, safety and efficacy of DNA vaccines
por: Beasley, David W. C.
Publicado: (2020)

Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
por: Malek, Alexandre E.
Publicado: (2021)

Efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis
por: Xi, An-ran, et al.
Publicado: (2022)

G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2019)

Functional characterization of GM-CSF induced monocyte subsets
por: Däbritz, J, et al.
Publicado: (2008)

Delivery of GM-CSF to Protect against Influenza Pneumonia
por: Subramaniam, Renuka, et al.
Publicado: (2015)

Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update
por: Lotfi, Noushin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k4t9qerav8dlqaod4kvjkbj70m